Search
for

    Sort by

    Research 271–300 of 305

    1. Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese Human Genomics · 2024 · 1 citations
    2. Food Administration and Not Genetic Variants Causes Pharmacokinetic Variability of Tadalafil and Finasteride Journal of personalized medicine · 2023 · 1 citations
    3. The adverse effects of commonly used medications on male fertility: a comprehensive review F&S Reviews · 2023 · 1 citations
    4. 5‐α reductase inhibitors and the risk of anaemia among men with benign prostatic hyperplasia: A population‐based cohort study British Journal of Clinical Pharmacology · 2022 · 1 citations
    5. Serenoa repens induced erectile dysfunction: Underdiagnosis and phytovigilance British Journal of Clinical Pharmacology · 2021 · 1 citations
    6. 69-Year-Old Man With Nasal Congestion and Pre-Syncope Mayo Clinic Proceedings · 2021 · 1 citations
    7. Determination of finasteride, indapamide and tiemonium methyl sulphate using surface plasmon resonance band of silver nanoparticles Reviews in separation sciences · 2020 · 1 citations
    8. Can we predict prostate size by scoring baldness? The relationship of androgenic alopecia and lower urinary tract symptoms. PubMed · 2019 · 1 citations
    9. Post-finasteride Syndrome: A Review of Current Literature Current Sexual Health Reports · 2018 · 1 citations
    10. Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor Daehan namseong gwahag hoeji · 2012 · 1 citations
    11. Benign Prostatic Hyperplasia Pharmacotherapy and Incident Ocular Surface Disease: Comparative Risk of Alpha-Blockers vs 5-Alpha Reductase Inhibitors Urology · 2026
    12. 3a-Phenylhexahydropentalene-1,6-dione Molbank · 2026
    13. Efficacy and safety of α-blockers plus 5α-reductase inhibitors for benign prostatic hyperplasia: a systematic review and meta-analysis European journal of medical research · 2026
    14. Depression risk of 5-alpha reductase inhibitors: impact of active-comparator versus non-drug user control groups on risk measurement Postgraduate Medicine · 2026
    15. Targeted Determination of Residual Sex Hormones in Cosmetics Using Magnetic Solid-Phase Extraction with Isotope-Labeled Internal Standards by UHPLC-MS/MS Molecules · 2025
    16. Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system The Journal of Sexual Medicine · 2025
    17. Exploration of the Possible Relationships Between Gut and Hypothalamic Inflammation and Allopregnanolone: Preclinical Findings in a Post-Finasteride Rat Model. PubMed · 2025
    18. Differential association between cumulative dose of 5α-reductase inhibitors and mortality Scientific Reports · 2025
    19. Post-finasteride syndrome - a true clinical entity? International Journal of Impotence Research · 2025
    20. Validation of Finasteride Tablets USP by HPLC Isocratic with UV Detector International Journal of Scientific Research in Science and Technology · 2025
    21. Efficacy, safety, and adverse effects of finasteride and dutasteride in treating benign prostatic hyperplasia: A retrospective cohort study Zanco Journal of Medical Sciences · 2024
    22. Bioprospecting of Potential Inhibitors of 5alpha Reductase 2 Inhibitors from Relevant Ethno-pharmacological Plants via In Silico Techniques Scientific African · 2024
    23. Comment on Current Investigations into the Postfinasteride Syndrome International Journal of Trichology · 2024
    24. Synchronous fluorescence as a green and selective method for the simultaneous determination of finasteride and tadalafil in dosage form and spiked human plasma Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · 2023
    25. 5-alpha reductase inhibitors use in prostatic disease and beyond Translational Andrology and Urology · 2023
    26. Adverse Effects of 5-Alpha-Reductase Inhibitors: a narrative review Revista Eletrônica Acervo Médico · 2022
    27. Symptoms of hypogonadism caused by 5α-reductase inhibitors International journal of family & community medicine · 2017
    28. The First Visit: Consult and Workup Before Sperm Banking Springer eBooks · 2017
    29. 5α-Reductases in Human Physiology: An Unfolding Story Endocrine Practice · 2012
    30. Saw Palmetto Humana Press eBooks · 2007